ProtoKinetix (PKTX) Stock Price, News & Analysis

Company Overview

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Key Stats

• Today's Range: $0.0087 to $0.0087
• 50-Day Range: $0.0081 to $0.0130
• 52-Week Range: $0.0080 to $0.0150
• Volume: N/A
• Average Volume: 117,936 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ProtoKinetix Stock Analysis - MarketRank™

ProtoKinetix scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for ProtoKinetix.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of ProtoKinetix is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of ProtoKinetix is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

ProtoKinetix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ProtoKinetix has recently increased by 3,400.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ProtoKinetix does not currently pay a dividend.

Dividend Growth

ProtoKinetix does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

ProtoKinetix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ProtoKinetix has recently increased by 3,400.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.8 / 5
• News Sentiment: -0.50

News Sentiment

ProtoKinetix has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for ProtoKinetix this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ProtoKinetix insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.87% of the stock of ProtoKinetix is held by insiders.

Percentage Held by Institutions

Only 0.04% of the stock of ProtoKinetix is held by institutions.

PKTX Stock Analysis - Frequently Asked Questions

How have PKTX shares performed this year?

ProtoKinetix's stock was trading at $0.01 at the beginning of 2025. Since then, PKTX shares have decreased by 13.0% and is now trading at $0.0087.
View the best growth stocks for 2025 here.

How do I buy shares of ProtoKinetix?

Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ProtoKinetix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ProtoKinetix investors own include Sangamo Therapeutics (SGMO), Abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), MSP Recovery (LIFW), Fulcrum Therapeutics (FULC), NVIDIA (NVDA) and Tenax Therapeutics (TENX).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:PKTX
• Previous Symbol: NASDAQ:PKTX
• CIK: 1128189
• Web: www.protokinetix.com
• Phone: (330) 445-4971
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A